Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2531
2.550
Why?
Smoking
20
2019
1607
1.190
Why?
Bronchi
13
2018
266
1.170
Why?
Carcinoma in Situ
5
2019
44
1.070
Why?
Carcinoma, Squamous Cell
10
2018
646
0.740
Why?
Carcinogens
4
2012
126
0.730
Why?
Chemoprevention
3
2019
95
0.700
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.700
Why?
Lung
16
2020
4086
0.590
Why?
Carcinoma, Small Cell
7
2008
171
0.480
Why?
Bronchoscopy
9
2019
219
0.480
Why?
Urethane
3
2012
43
0.470
Why?
Bronchopulmonary Dysplasia
2
2019
387
0.460
Why?
Sputum
8
2019
304
0.450
Why?
Iloprost
2
2012
45
0.440
Why?
Pulmonary Alveoli
4
2012
410
0.440
Why?
Hyperplasia
7
2011
176
0.440
Why?
Precancerous Conditions
7
2020
166
0.430
Why?
Neprilysin
3
1998
45
0.410
Why?
Quinazolines
2
2012
250
0.380
Why?
Biomarkers, Tumor
7
2015
1236
0.380
Why?
Biopsy
11
2019
1093
0.380
Why?
Piperidines
2
2012
215
0.370
Why?
Antineoplastic Agents
4
2013
2161
0.370
Why?
DNA Copy Number Variations
1
2011
178
0.340
Why?
Bombesin
5
1998
11
0.340
Why?
Genetic Markers
1
2011
345
0.330
Why?
Amidohydrolases
3
1998
31
0.320
Why?
Neurosecretory Systems
4
2004
31
0.310
Why?
Ki-67 Antigen
3
2015
110
0.310
Why?
Isotretinoin
1
2009
24
0.310
Why?
Tocopherols
1
2009
26
0.310
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1108
0.300
Why?
Vasodilator Agents
1
2011
329
0.300
Why?
ErbB Receptors
1
2012
613
0.300
Why?
Membrane Proteins
2
2008
1153
0.280
Why?
Neovascularization, Pathologic
6
2015
296
0.280
Why?
Mass Screening
3
2008
1287
0.270
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
1030
0.270
Why?
Respiratory Mucosa
2
2008
321
0.250
Why?
Adenocarcinoma
6
2012
882
0.240
Why?
Hypoxia
1
2012
1137
0.230
Why?
Chromosomes, Human, Pair 3
4
2000
48
0.220
Why?
Carcinoma, Bronchogenic
2
2002
20
0.210
Why?
Chromosome Aberrations
4
2013
158
0.200
Why?
Middle Aged
28
2019
33792
0.200
Why?
Tomography, Spiral Computed
1
2002
32
0.200
Why?
Aged
25
2019
24182
0.190
Why?
Humans
53
2020
138651
0.180
Why?
Smokers
2
2019
141
0.180
Why?
Sensitivity and Specificity
10
2010
1958
0.180
Why?
Female
33
2019
73913
0.170
Why?
Placebos
2
2019
197
0.170
Why?
Lung Diseases
5
2015
777
0.170
Why?
Double-Blind Method
2
2019
1946
0.170
Why?
Small Cell Lung Carcinoma
2
2012
115
0.170
Why?
Tomography, X-Ray Computed
2
2020
2703
0.160
Why?
Male
30
2019
68216
0.160
Why?
Neuropeptides
4
1998
75
0.160
Why?
Tumor Cells, Cultured
6
1998
949
0.160
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
111
0.150
Why?
Remission Induction
1
2019
295
0.150
Why?
In Situ Hybridization, Fluorescence
6
2010
309
0.140
Why?
Peptides
3
1996
984
0.140
Why?
Blotting, Western
4
2012
1229
0.140
Why?
Genes, p53
1
1997
70
0.140
Why?
Lung Diseases, Obstructive
1
1997
47
0.140
Why?
Antibodies, Monoclonal
3
2010
1437
0.130
Why?
Immunohistochemistry
8
2015
1732
0.130
Why?
Point Mutation
1
1997
239
0.130
Why?
Proteomics
2
2015
1113
0.120
Why?
Radiation Injuries, Experimental
1
1996
22
0.120
Why?
Bradykinin
1
1996
46
0.120
Why?
Endopeptidases
1
1996
91
0.120
Why?
Chromosomal Instability
2
2013
20
0.120
Why?
Smoking Cessation
1
2019
434
0.120
Why?
Hyperoxia
1
1996
90
0.110
Why?
Multiple Pulmonary Nodules
1
2015
21
0.110
Why?
Mice
10
2012
17848
0.110
Why?
Animals
13
2013
37309
0.110
Why?
Gene Expression
3
1998
1494
0.110
Why?
Methylcholanthrene
2
2012
22
0.110
Why?
Antigens
1
1996
356
0.110
Why?
Butylated Hydroxytoluene
2
2012
37
0.110
Why?
Mice, Transgenic
5
2009
2177
0.110
Why?
Risk Factors
5
2019
10398
0.100
Why?
Microarray Analysis
1
2013
117
0.100
Why?
Stem Cells
1
2018
598
0.100
Why?
Algorithms
3
2020
1718
0.100
Why?
Aged, 80 and over
8
2015
7683
0.100
Why?
Mutation
4
2000
3998
0.100
Why?
Epithelium
4
2018
317
0.100
Why?
Intramolecular Oxidoreductases
2
2004
68
0.100
Why?
Carcinoma, Large Cell
1
2012
15
0.100
Why?
Risk
5
2012
912
0.100
Why?
Biological Products
1
1996
229
0.100
Why?
Cytochrome P-450 Enzyme System
2
2004
159
0.100
Why?
Epithelial Cells
3
2007
1102
0.090
Why?
Receptors, Bombesin
1
2012
2
0.090
Why?
Bronchoalveolar Lavage Fluid
3
2002
648
0.090
Why?
Immunoenzyme Techniques
1
2012
209
0.090
Why?
Volatile Organic Compounds
1
2012
61
0.090
Why?
Cell Division
4
2000
791
0.090
Why?
Case-Control Studies
8
2012
3581
0.090
Why?
Sleep Apnea Syndromes
1
2012
90
0.090
Why?
Dose-Response Relationship, Drug
2
2010
2045
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2012
140
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
54
0.090
Why?
Veterans
1
2002
1477
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.090
Why?
Epithelial-Mesenchymal Transition
1
2012
211
0.080
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
247
0.080
Why?
Antioxidants
2
2012
593
0.080
Why?
Plants, Toxic
1
1989
25
0.080
Why?
Cell Line
5
2013
2874
0.080
Why?
Calcium
1
1996
1185
0.080
Why?
Somatomedins
1
2009
28
0.080
Why?
Proteins
1
1996
1014
0.080
Why?
Genome-Wide Association Study
2
2013
1398
0.080
Why?
Predictive Value of Tests
4
2009
2039
0.080
Why?
Disease Progression
5
2018
2734
0.080
Why?
Cell Proliferation
2
2018
2474
0.080
Why?
Bronchial Neoplasms
1
2009
15
0.080
Why?
Intracellular Signaling Peptides and Proteins
2
2011
463
0.070
Why?
Chromosome Deletion
1
1989
114
0.070
Why?
Adult
16
2018
38296
0.070
Why?
Neoplasms, Glandular and Epithelial
1
2009
49
0.070
Why?
Airway Obstruction
3
2009
159
0.070
Why?
Respiratory System
1
1989
155
0.070
Why?
GPI-Linked Proteins
1
2008
76
0.070
Why?
Neoplasm Invasiveness
4
2015
501
0.070
Why?
Fluorescence
3
2009
159
0.070
Why?
Polymorphism, Genetic
1
2011
636
0.070
Why?
Alkaline Phosphatase
1
2008
151
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Isoenzymes
1
2008
304
0.070
Why?
Molecular Targeted Therapy
1
2010
414
0.070
Why?
Cell Transformation, Neoplastic
1
2009
333
0.070
Why?
Inflammation
1
2018
2857
0.070
Why?
Molecular Sequence Data
5
1998
2928
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
263
0.070
Why?
Fibroblasts
3
1998
1002
0.070
Why?
Pulmonary Surfactants
2
1999
106
0.070
Why?
Exons
2
1998
355
0.060
Why?
MicroRNAs
1
2012
680
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2143
0.060
Why?
Follow-Up Studies
2
2015
5160
0.060
Why?
Early Detection of Cancer
1
2010
432
0.060
Why?
ROC Curve
3
2015
566
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
856
0.060
Why?
Recombinant Proteins
3
1998
1358
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
430
0.060
Why?
Biomarkers
3
2010
4111
0.060
Why?
RNA, Messenger
3
1998
2817
0.060
Why?
Polymerase Chain Reaction
3
1998
1049
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
25
0.050
Why?
Acromegaly
1
2004
16
0.050
Why?
Protein Kinase Inhibitors
1
2010
914
0.050
Why?
Cytokines
1
2012
2084
0.050
Why?
Adrenocorticotropic Hormone
1
2004
149
0.050
Why?
Rats
4
2004
5594
0.050
Why?
Smoke
1
2004
144
0.050
Why?
Base Sequence
3
1998
2182
0.050
Why?
Solitary Pulmonary Nodule
1
2002
21
0.050
Why?
Neoplasm Recurrence, Local
1
2009
1065
0.050
Why?
Metaplasia
2
2018
58
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
551
0.050
Why?
Cross-Sectional Studies
2
2018
5523
0.050
Why?
Sex Factors
1
2007
2058
0.040
Why?
Hospitals, Veterans
1
2002
255
0.040
Why?
Pulmonary Fibrosis
2
1998
398
0.040
Why?
Radiation Dosage
1
2002
190
0.040
Why?
Reproducibility of Results
1
2008
3311
0.040
Why?
Gene Expression Regulation
1
1989
2602
0.040
Why?
Cohort Studies
4
2015
5729
0.040
Why?
Amino Acid Sequence
3
1994
2162
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Autocrine Communication
1
1998
41
0.040
Why?
Desmoglein 3
1
2018
15
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Loss of Heterozygosity
2
2013
51
0.040
Why?
Signal Transduction
3
1998
5091
0.040
Why?
Light
1
2001
393
0.040
Why?
Feasibility Studies
1
2002
970
0.040
Why?
DNA Primers
2
1998
509
0.040
Why?
Up-Regulation
2
2005
851
0.040
Why?
Bronchial Diseases
1
2018
38
0.040
Why?
Paracrine Communication
1
1998
66
0.040
Why?
Neoplasm Transplantation
1
1998
251
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
40
0.030
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
13
0.030
Why?
Polymorphism, Single-Stranded Conformational
1
1997
25
0.030
Why?
Cell Cycle Checkpoints
1
2018
97
0.030
Why?
Time
1
2018
88
0.030
Why?
Genes, Tumor Suppressor
1
1998
81
0.030
Why?
Gene Expression Profiling
1
2005
1755
0.030
Why?
Alveolitis, Extrinsic Allergic
1
1998
96
0.030
Why?
Polymorphism, Restriction Fragment Length
1
1997
68
0.030
Why?
Likelihood Functions
1
1998
143
0.030
Why?
DNA, Complementary
1
1998
276
0.030
Why?
Gene Expression Regulation, Enzymologic
1
1998
277
0.030
Why?
Codon
1
1997
92
0.030
Why?
Neoplasm Staging
2
2012
1376
0.030
Why?
Introns
1
1998
256
0.030
Why?
United States
2
2011
15018
0.030
Why?
Mice, Nude
1
1998
689
0.030
Why?
Membrane Glycoproteins
1
1999
500
0.030
Why?
Treatment Outcome
1
2011
10938
0.030
Why?
Immunoassay
2
1998
112
0.030
Why?
Enzyme Activation
1
1998
819
0.030
Why?
Incidence
3
2010
2830
0.030
Why?
RNA, Neoplasm
1
1996
79
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Image Processing, Computer-Assisted
1
2020
755
0.030
Why?
Mesothelioma
1
1996
45
0.030
Why?
Sequence Analysis, DNA
1
1998
827
0.030
Why?
Antigens, CD
2
1998
537
0.030
Why?
Proto-Oncogene Proteins
1
2018
623
0.030
Why?
Machine Learning
1
2020
517
0.030
Why?
Cell Cycle Proteins
1
2018
615
0.030
Why?
Databases, Factual
1
2020
1399
0.030
Why?
Receptors, Peptide
1
1994
19
0.030
Why?
Myelin Sheath
1
1996
166
0.030
Why?
Rh-Hr Blood-Group System
1
1994
14
0.030
Why?
Erythrocyte Membrane
1
1994
54
0.030
Why?
Blotting, Southern
1
1993
75
0.030
Why?
Blotting, Northern
1
1993
201
0.030
Why?
Prospective Studies
3
2012
7639
0.030
Why?
Neoplasm Metastasis
1
1996
668
0.030
Why?
DNA, Neoplasm
1
1993
158
0.020
Why?
Cells, Cultured
2
2007
4175
0.020
Why?
Solid Phase Microextraction
1
2012
9
0.020
Why?
Endoscopy
1
2015
320
0.020
Why?
Dinoprostone
2
2004
192
0.020
Why?
Fluorescent Antibody Technique
1
1993
384
0.020
Why?
Breath Tests
1
2012
76
0.020
Why?
Cloning, Molecular
1
1993
535
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
135
0.020
Why?
Colorado
1
2002
4528
0.020
Why?
Enzyme Inhibitors
1
1996
850
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2018
1388
0.020
Why?
Liver Neoplasms
1
1998
761
0.020
Why?
Iceland
1
2011
11
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
13
0.020
Why?
Spain
1
2011
45
0.020
Why?
Netherlands
1
2011
86
0.020
Why?
Respiratory Tract Diseases
1
1992
181
0.020
Why?
Cattle
1
1993
996
0.020
Why?
Administration, Oral
1
2012
789
0.020
Why?
Rats, Sprague-Dawley
1
1996
2494
0.020
Why?
Meta-Analysis as Topic
1
2011
186
0.020
Why?
Severity of Illness Index
1
2018
2861
0.020
Why?
Carrier Proteins
1
1994
739
0.020
Why?
Receptor, IGF Type 1
1
2009
64
0.020
Why?
Prognosis
2
2012
4015
0.020
Why?
Area Under Curve
1
2010
315
0.020
Why?
Flow Cytometry
1
1993
1197
0.020
Why?
International Agencies
1
2009
34
0.020
Why?
Cystic Fibrosis
1
1998
1106
0.020
Why?
Erythrocytes
1
1994
711
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
591
0.020
Why?
Mass Spectrometry
1
2010
741
0.020
Why?
Pilot Projects
1
2012
1757
0.020
Why?
Genome, Human
1
2009
418
0.020
Why?
Models, Statistical
1
2010
667
0.020
Why?
Amino Acids
1
1989
499
0.020
Why?
Genotype
1
2011
1873
0.010
Why?
Disease Models, Animal
1
1996
4333
0.010
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
108
0.010
Why?
Genomics
1
2009
804
0.010
Why?
Epoprostenol
1
2004
136
0.010
Why?
Bronchiolitis
1
2004
81
0.010
Why?
Autoantibodies
1
2010
1454
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
981
0.010
Why?
Fruit
1
2003
146
0.010
Why?
Vegetables
1
2003
161
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
760
0.010
Why?
Genetic Predisposition to Disease
1
2011
2368
0.010
Why?
Respiratory Function Tests
1
2004
559
0.010
Why?
Pituitary Neoplasms
1
2004
189
0.010
Why?
Adenoma
1
2004
225
0.010
Why?
Regression Analysis
1
2003
1015
0.010
Why?
Single-Blind Method
1
2001
286
0.010
Why?
Weight Gain
1
2004
538
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
50
0.010
Why?
Carcinoma
1
2001
230
0.010
Why?
Bronchoscopes
1
1998
3
0.010
Why?
RNA
1
2005
928
0.010
Why?
Endoglin
1
1998
18
0.010
Why?
Random Allocation
1
1998
364
0.010
Why?
Genetic Linkage
1
1998
292
0.010
Why?
Retrospective Studies
1
2015
15860
0.010
Why?
Reference Values
1
1998
804
0.010
Why?
Comorbidity
1
2001
1655
0.010
Why?
Linear Models
1
1998
856
0.010
Why?
Longitudinal Studies
1
2003
2838
0.010
Why?
Tumor Suppressor Protein p53
1
2000
527
0.010
Why?
Analysis of Variance
1
1998
1320
0.010
Why?
Diet
1
2003
1287
0.010
Why?
Receptors, Cell Surface
1
1998
393
0.010
Why?
Alleles
1
1998
887
0.010
Why?
Risk Assessment
1
2004
3459
0.010
Why?
Young Adult
1
2011
13322
0.010
Why?
Infant, Premature
1
1998
580
0.010
Why?
Chromatography, Affinity
1
1994
86
0.010
Why?
CD47 Antigen
1
1994
38
0.010
Why?
Endothelium, Vascular
1
2000
934
0.010
Why?
Genes
1
1994
229
0.010
Why?
Moths
1
1994
45
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
339
0.010
Why?
Cytoplasm
1
1994
270
0.010
Why?
Carcinoid Tumor
1
1992
23
0.010
Why?
Chromosome Mapping
1
1994
515
0.010
Why?
Lymphocytes
1
1994
399
0.010
Why?
Transfection
1
1994
942
0.010
Why?
Adolescent
1
2011
21528
0.010
Why?
Mice, Inbred BALB C
1
1994
1261
0.010
Why?
Dyspnea
1
1992
251
0.010
Why?
Binding Sites
1
1994
1318
0.010
Why?
Fibrosis
1
1992
542
0.010
Why?
Phenotype
1
1998
3160
0.000
Why?
Aging
1
1998
1859
0.000
Why?
Infant, Newborn
1
1998
6143
0.000
Why?
Infant
1
1998
9565
0.000
Why?
Child, Preschool
1
1998
11130
0.000
Why?
Child
1
1998
21883
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)